FBL and metabolic dysfunction-associated steatotic liver disease: In a meta-analysis, Fib-4 and NFS, rather than the AST-to-platelet ratio index, might be a significant noninvasive fibrosis scoring system for estimating higher CVD events in patients with NAFLD [33].